These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 32482673)
1. Nelson K; Rubio-Aparicio D; Sun D; Dudley M; Lomovskaya O Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482673 [TBL] [Abstract][Full Text] [Related]
2. Nelson K; Rubio-Aparicio D; Tsivkovski R; Sun D; Totrov M; Dudley M; Lomovskaya O Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868334 [TBL] [Abstract][Full Text] [Related]
3. Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963 [TBL] [Abstract][Full Text] [Related]
4. Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Lomovskaya O; Nelson K; Rubio-Aparicio D; Tsivkovski R; Sun D; Dudley MN Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229498 [TBL] [Abstract][Full Text] [Related]
5. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals. Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421 [TBL] [Abstract][Full Text] [Related]
6. Lomovskaya O; Rubio-Aparicio D; Nelson K; Sun D; Tsivkovski R; Castanheira M; Lindley J; Loutit J; Dudley M Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782010 [TBL] [Abstract][Full Text] [Related]
7. Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases. Lomovskaya O; Tsivkovski R; Nelson K; Rubio-Aparicio D; Sun D; Totrov M; Dudley MN Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229489 [TBL] [Abstract][Full Text] [Related]
8. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Shortridge D; Kantro V; Castanheira M Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238 [TBL] [Abstract][Full Text] [Related]
9. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae. Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018 [TBL] [Abstract][Full Text] [Related]
10. The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant Lomovskaya O; Rubio-Aparicio D; Tsivkovski R; Loutit J; Dudley M Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216821. PubMed ID: 34902261 [TBL] [Abstract][Full Text] [Related]
11. Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases. Tsivkovski R; Totrov M; Lomovskaya O Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32152086 [TBL] [Abstract][Full Text] [Related]
13. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684 [TBL] [Abstract][Full Text] [Related]
14. Sabet M; Tarazi Z; Griffith DC Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839224 [TBL] [Abstract][Full Text] [Related]
15. Meropenem-Vaborbactam Activity against Carbapenem-Resistant Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207 [TBL] [Abstract][Full Text] [Related]
16. Intrinsic Antibacterial Activity of Xeruborbactam Sun D; Tsivkovski R; Pogliano J; Tsunemoto H; Nelson K; Rubio-Aparicio D; Lomovskaya O Antimicrob Agents Chemother; 2022 Oct; 66(10):e0087922. PubMed ID: 36102663 [TBL] [Abstract][Full Text] [Related]
17. Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022). Sader HS; Carvalhaes CG; Kimbrough JH; Mendes RE; Castanheira M Int J Antimicrob Agents; 2024 Apr; 63(4):107113. PubMed ID: 38354826 [TBL] [Abstract][Full Text] [Related]
18. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance. Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y mBio; 2020 Mar; 11(2):. PubMed ID: 32184250 [TBL] [Abstract][Full Text] [Related]
19. Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Zalacain M; Achard P; Llanos A; Morrissey I; Hawser S; Holden K; Toomey E; Davies D; Leiris S; Sable C; Ledoux A; Bousquet J; Castandet J; Lozano C; Everett M; Lemonnier M Antimicrob Agents Chemother; 2024 Mar; 68(3):e0112023. PubMed ID: 38289044 [TBL] [Abstract][Full Text] [Related]
20. Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019-2020). Boattini M; Comini S; Bianco G; Iannaccone M; Casale R; Cavallo R; Costa C J Chemother; 2023 May; 35(3):198-204. PubMed ID: 35731718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]